Top Tweets for #Selution
We have just finished live transmission from Yeditepe University hospital cath labs. to #JIMGISE2026 meeting treating patient with only DCB of LAD, D and OM. This is important collaboration with JIMGISE and #TSC. Looking forward for more activities. #DCB #cardiology #selution

With the great results of #SELUTION4ISR & #SELUTION DeNovo trials at #TCT2025, the "lowly balloon" is being reborn for PCI. Since I'm always thinking about #AngioHistory, I thought this clip from my 1985 (i.e. pre-stent) interview w Andreas Gruentzig would be appropriate today.
Results from #SELUTION are encouraging, but some aspects deserve attention: 👇
1️⃣ Observed TVF rate of 4.4% (DES) was lower than expected (assumed rate 6%)
2️⃣ 50% non-inferiority margin is somewhat large. With a more conservative approach, including a 33% margin, non-inferiority wouldn’t hold (Upper CI 2.38% higher than 1.60%)
3️⃣ Periprocedural MI ≈1%: very low, raising possible underreporting.
Overall, this is a technology with a great potential, but let’s safeguard it through trial evaluation and critical scrutiny, not overstatement. We should embrace innovation with hope and thoughtful assessment, not hype.
@mmamas1973 @evandrofilhobr @djc795 @Costa_F_8 @DFCapodanno @mirvatalasnag @drjohnm @HadyLichaaMD @DLBHATTMD @SVRaoMD @Hragy @dukwoo_park @pash22 @Ortega_Paz @EricSecemskyMD @BURZOTTA_F @drptca @kaulcsmc @kevinjamescroce @GGStefanini
SELUTION DeNovo - non inferiority for TVF at 1 yr demonstrated. Randomisation before lesion prep
➡️ 20% DES use in DEB arm
➡️ 50% non inferiority margin of overall tvf in both arms !!!!!
➡️ TVF 4.4 vs 5.3% in des and deb arms
This is a landmark moment- analogous to introduction of DES (even with generous non inferiority margin) #TCT2025 @crfheart
Wild clapping in audience @Hragy @jgranadacrf @mirvatalasnag @drptca @SrihariNaiduMD @realarainmd @DrAsifQasim @DavidWienerMD @sbrugaletta @alaide_chief

Finally! #Sirolimus-eluting balloon (#Selution) demonstrates non-inferiority to DES in de novo coronary lesions! Game-changing implications for coronary intervention! #PCI #TCT2025 #LeaveNothingBehind #DCB #DEB #SelutionDeNovo #CardioTwitter #InterventionalCardiology
SELUTION DeNovo 🇪🇺 | #TCT2025
Large, pragmatic strategy trial: sirolimus DCB-first vs contemporary DES for de novo lesions.
Unique strategy: patients randomized before lesion preparation — unlike prior DCB studies.
✅ Non-inferior for 1-year TVF (5.3% vs 4.4%)
💀 Death, MI, thrombosis all similar
🧠 80% of DCB patients avoided a stent
⚠️ Slightly higher TVR (3.3% vs 2.1%)
🔍 Low intravascular imaging use (~16%) outcomes could be even stronger with optimized prep & imaging guidance.
A real step toward “leave nothing behind.”
#DCB #InterventionalCardiology #TCT2025

With the great results of #SELUTION4ISR & #SELUTION DeNovo trials at #TCT2025, the "lowly balloon" is being reborn for PCI. Since I'm always thinking about #AngioHistory, I thought this clip from my 1985 (i.e. pre-stent) interview w Andreas Gruentzig would be appropriate today.
@mmamas1973 We don’t want to leave metal behind however the early POBA experience was marred by abrupt vessel closure..back to that practice requires evidence #SELUTION De Novo is certainly an important step in that direction
@CERC_CRO is proud to partner with @cordis for another game changing trial #Selution study which showed that lesion préparation was systematic and bail out decreased with increasing site experience with the device
#CardioTwitter #Cardiology #europcr2024
@PCRonline

This is looking like it’s going to be great discussion @LINCmeeting on the 7th of June. Join us Online or in person. @MedallianceSA #selution #CLI #BTK #SirolimusDEB #GlobalExperts
We are so honored to have been selected as a finalist for the Supes' Choice Awards in the category "SEL Solution of the Year"! Created by @IEI_K12, Supes' Choice is the only education industry awards judged exclusively by school district superintendents.
#SELution #supeschoice

#MTF, #UMB und #Selution: Das sind die Gewinner der diesjährigen #Partnerawards von Sophos. Alle drei erhielten zudem noch ein Geschenk; eines der Unternehmen durfte sich gleich dreifach freuen. @umb1978 @Sophos #Cybersecurity https://t.co/XAHJJi5tK8

📍 Wir sind dabei am @Cisco Cisco Live Event in Barcelona!
Wir freuen uns auf spannende Keynotes und innovative Lösungen.
#cisco #ciscolive #ciscoliveeurope #barcelona #selution #staytuned @Cisco_CH @CiscoLiveEurope

Also Swiss drug-coated balloon maker MedAlliance got $22m equity financing from Shenzhen Salubris Pharma to advance #Selution DCB with sirolimus-delivering micro-reservoir in coating #medtech #cardiology #vascular
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
241.7M followers

Barack Obama 
@barackobama
119M followers

Cristiano Ronaldo 
@cristiano
114.3M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.2M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.4M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
89.9M followers

Taylor Swift 
@taylorswift13
83.9M followers

Lady Gaga 
@ladygaga
75.4M followers

Virat Kohli 
@imvkohli
73.3M followers

Kim Kardashian 
@kimkardashian
70.9M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
66.3M followers

Bill Gates 
@billgates
65.1M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.3M followers

CNN 
@cnn
61.8M followers

X 
@x
60.7M followers






















